A new paper from Imperial scientists has identified an antiviral metabolite as a potential serum biomarker for viral infections, including SARS-CoV-2. The work is a collaboration between researchers in MDR's @NPCUK1 and @ImperialInfect
https://t.co/gBUUJz2GNS